Spero Therapeutics Funding: $250M Raised, Series A (2014)
Spero Therapeutics is based in Cambridge, Massachusetts. It has raised $250M in total funding. Latest round: Series A.
Spero Therapeutics funding overview
Spero Therapeutics is based in Cambridge, Massachusetts. Spero Therapeutics has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in January 2014. The round record for Spero Therapeutics runs through 2014; nothing later has been disclosed. Investors on record include Atlas Venture, New Enterprise Associates, Gates Foundation, Biogen. 4 distinct backers are named across the disclosed rounds.
Spero Therapeutics at a glance
Total raised
$250M
Latest round
Series A
Latest round date
January 2014
Headquarters
Cambridge, Massachusetts
Notable investors
Atlas Venture, New Enterprise Associates, Gates Foundation, Biogen
Frequently asked about Spero Therapeutics funding
How much has Spero Therapeutics raised?
Spero Therapeutics has raised $250M in total disclosed funding across the rounds on record.
Who has invested in Spero Therapeutics?
Atlas Venture, New Enterprise Associates, Gates Foundation, Biogen are named among the investors backing Spero Therapeutics.
What was the latest Spero Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2014.
Where is Spero Therapeutics based?
Spero Therapeutics is based in Cambridge, Massachusetts.
When did Spero Therapeutics last raise?
The last disclosed Spero Therapeutics round closed in January 2014 at Series A.
Totals shown for Spero Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
